VC firm / fund
Eli Lilly and Company
Eli Lilly and Company has backed 3 tracked startups across Health, totalling $237M raised. Public investment activity below — sourced from Datapile’s funding database.
3
Tracked deals
$237M
Total raised
2026
Active since
$77M
Median round
What Eli Lilly and Company invests in
Round-size distribution
Total round sizes (not this investor’s specific check) across their tracked deals.
Frequent co-investors
Adage1BVF Partners1BVF Partners, L.P.1Catalio Capital Management1Columbia Threadneedle1Deep Track Capital1Emerson Collective1Euclidean Capital1Insight Partners1Invus1MRL Ventures Fund1NVIDIA1
Recent investments
| Company | Sector | Round | When |
|---|---|---|---|
| Absci Corporation | Health | $100M | Sep 2026 |
| Superluminal Medicines | Health | $60M · Series B | Sep 2026 |
| InduPro | Health | $77M · Series B | Aug 2026 |
Reach Eli Lilly and Company and 326,000+ more investors
Datapile tracks verified contacts, focus areas, and full deal history for investors worldwide.
Aggregated from public funding announcements in Datapile’s database. Investor names are matched from round data and may include name variants.